Subconjunctival therapy by cubic liquid crystalline nanoparticles to deliver Triamcinolone acetonide for the management of diabetic Retinopathy: In vivo evidences
-
Published:2023-11
Issue:
Volume:646
Page:123443
-
ISSN:0378-5173
-
Container-title:International Journal of Pharmaceutics
-
language:en
-
Short-container-title:International Journal of Pharmaceutics
Author:
Sharadha M.ORCID,
Vishal Gupta N.,
Rahamathulla MohamedORCID,
Muqtader Ahmed Mohammed,
Ayesha Farhana Syeda,
Osmani Riyaz Ali M.,
Veeranna Balamuralidhara,
Koteshwara K.B.
Subject
Pharmaceutical Science
Reference49 articles.
1. Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes;Alessi;Diabetol. Metab. Syndr.,2020
2. Transscleral drug delivery to the retina and choroid;Ambati;Prog. Retin. Eye Res.,2002
3. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy;Arrigo;Ann. Med.,2022
4. Badr, M.Y., Abdulrahman, N.S., Schatzlein, Andreas.G., Uchegbu, Ijeoma.F., 2021. A polymeric aqueous tacrolimus formulation for topical ocular delivery. Int. J. Pharm. 599, 120364. https://doi.org/10.1016/j.ijpharm.2021.120364.
5. Diabetic macular oedema: pathophysiology, management challenges and treatment resistance;Bahrami;Diabetologia,2016